Lacosamide Dr. Reddy’s

Lacosamide, the active ingredient in Lacosamide Dr. Reddy’s, is an anticonvulsant presented as an injectable solution for intravenous use. It treats partial‑onset seizures and is employed as adjunctive therapy in patients with epilepsy.

GNH USA supplies Lacosamide Dr. Reddy’s as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is used in the management of seizure disorders, specifically targeting partial‑onset seizures in epilepsy.

Partial‑onset seizures: reduces seizure frequency as adjunctive therapy. Adjunctive therapy for epilepsy: improves overall seizure control when added to existing regimens. Refractory focal epilepsy: provides an additional option for patients not responding adequately to other antiepileptics.

Lacosamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: feeling of lightheadedness or unsteadiness. - Nausea: mild stomach upset. - Fatigue: increased tiredness. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Respiratory depression: reduced breathing effort.

Lacosamide requires careful monitoring in several clinical situations.

Renal impairment: adjust monitoring and consider dose modification. Cardiac conduction disorders: obtain baseline ECG and monitor for PR‑interval changes. Pregnancy: category C, weigh maternal benefits against potential fetal risks. Concomitant CNS depressants: may increase sedation and respiratory effects. Hypersensitivity: discontinue immediately if allergic reaction occurs. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lacosamide can interact with other medicines, necessitating vigilance.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may raise lacosamide plasma concentrations. - Other sodium‑channel blockers: risk additive cardiac conduction effects. - Drugs that prolong PR interval: can cause severe conduction abnormalities.

Moderate Interactions (Monitor Closely): - CYP2C19 inhibitors: may modestly increase lacosamide levels. - Alcohol: can enhance central nervous system depression. - Anticoagulants: may affect bleeding risk and require monitoring.